Whalesbook
Religare Enterprises mein aaj market mein badi khabar aayi hai! Company apne business ko do alag alag listed companies mein baantne ja rahi hai. Ek hogi sirf health insurance ke liye, jiska naam hoga Religare Enterprises (REL), aur doosri lending aur broking ke liye, jiska naam hoga Religare Finvest (RFL).
Aur toh aur, Burman Group, jo ab company ke promoter ban gaye hain, ne ₹750 Crore ka paisa dala hai preferential rights issue ke through. Isse unka stake badh kar 30.3% ho gaya hai. Yeh paisa company ke growth aur future plans ke liye bahut kaam aayega.
Is structural change se investors ko clear picture milegi. Alag hone ke baad, health insurance aur lending businesses ko apne specific growth paths par focus karne mein aasani hogi. Burman Group ka backing company ko financial stability aur direction dega, especially demerger process ke dauraan.
Pata hai, Religare Finvest (RFL) pehle thoda problematic tha, financial issues the. Par ab current management use debt-free bana rahi hai aur ek clean balance sheet ke saath future operations ke liye ready kar rahi hai. Toh aage shareholders ko do alag alag listed investment opportunities milengi – ek health insurance mein growth ke liye aur doosri stable lending business ke liye.
But yahan kuch risks bhi hain jin par nazar rakhni hogi:
- Equity investments par ₹64 Crore ka mark-to-market loss hua hai, jo market volatility dikhata hai.
- Housing finance division abhi bhi loss mein chal raha hai, FY26 mein ₹18.6 Crore ka loss hua hai. Isko recover hone mein 12-18 months lag sakte hain.
- Lakshmi Vilas Bank (LVB) ke against ek legal case chal raha hai jismein fraudulent fixed deposit se related paisa recover karna hai.
Agar competitors ki baat karein toh, Care Health ka business India ke badhte health insurance market mein Star Health jaisi companies ke saath compete kar raha hai. Religare Finvest NBFC lending space mein hai, jahan Cholamandalam jaisi badi players hain, par RFL debt-free status aur high CRAR ke karan alag hai.
Kuch important numbers jo dekhne layak hain:
- Care Health ka retail health segment 34% annual growth dikha raha hai.
- Religare Finvest ka CRAR 261% hai.
- Religare Broking ne ₹22 Crore ka PAT kamaya, jabki top-line revenue 2% gira.
Aage kya dekhna hai investors ko:
- Demerger process aur regulatory approvals ke timelines.
- Housing finance business ka targeted profitability ki taraf progress.
- Lakshmi Vilas Bank fraudulent FD case ka resolution aur potential recovery.
- Care Health ka 18-24% growth guidance aur combined ratio 100% ke aas paas rakhne ka plan.
- Demerger ke baad koi aur strategic investor aata hai ya nahi.